sertraline has been researched along with Heart Failure in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 13 (86.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groban, L; Kitzman, DW; Register, TC; Shively, CA | 1 |
| Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE | 1 |
| Boyle, SH; Hall, R; Jiang, W; Krishnan, R; O'Connor, CM; Prybol, K; Rogers, JG; Steffens, DC; Streilein, RD; Xiong, GL | 1 |
| Arias, RM; Callwood, DD; Cuffe, MS; Henke, E; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, C; Silva, SG; Zakhary, B | 1 |
| Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J | 1 |
| Douzenis, A; Flevari, P; Ikonomidis, I; Iliodromitis, E; Kremastinos, DT; Leftheriotis, D; Liapis, C; Lykouras, L; Paraskevaidis, I | 1 |
| Goodlin, SJ | 1 |
| Arias, RM; Callwood, DD; Cuffe, MS; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, CM; Rivelli, SK; Silva, SG; Stough, WG; Zakhary, B | 1 |
| Arias, RM; Cuffe, MS; Jiang, W; Krishnan, R; Kuchibhatla, M; Martsberger, C; O'Connor, CM | 1 |
| Andreadou, I; Antonellos, N; Douzenis, A; Ikonomidis, I; Kremastinos, D; Lykouras, E; Markantonis-Kiroudis, S; Michalakeas, CA; Nikolaou, M; Paraskevaidis, I; Parissis, JT; Varounis, C | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Fillenbaum, GG; Kuchibhatla, MN | 1 |
| Baillie, R; Cuffe, M; Fiuzat, M; Jiang, W; Kaddurah-Daouk, R; Krishnan, R; Kuchibhatla, M; Martsberger, C; O'Connor, C; Oken, H; Shaw, LK; Steffens, DC | 1 |
| Fiuzat, M; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, CM; Xiong, GL | 1 |
| Fountoulaki, K; Kremastinos, DT; Paraskevaidis, I; Parissis, J | 1 |
1 review(s) available for sertraline and Heart Failure
| Article | Year |
|---|---|
Sertraline for the treatment of depression in coronary artery disease and heart failure.
Topics: Animals; Antidepressive Agents; Comorbidity; Coronary Artery Disease; Depression; Heart Failure; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
6 trial(s) available for sertraline and Heart Failure
| Article | Year |
|---|---|
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
Topics: Antidepressive Agents; Depression; Double-Blind Method; Heart Failure; Humans; Research Design; Sertraline | 2008 |
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2010 |
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Depression; Female; Heart Failure; Humans; Male; Middle Aged; Sertraline | 2010 |
Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Depression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Time Factors; Treatment Outcome | 2011 |
Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.
Topics: Aged; Antidepressive Agents; Biomarkers; Cause of Death; Chi-Square Distribution; Chronic Disease; Depressive Disorder, Major; Disease-Free Survival; Down-Regulation; Fatty Acids, Omega-3; Female; Flame Ionization; Heart Failure; Humans; Male; Middle Aged; North Carolina; Prognosis; Proportional Hazards Models; Sertraline; Survival Analysis; Survival Rate; Time Factors | 2012 |
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Comorbidity; Depression; Female; Health Status; Heart Failure; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Self Report; Sertraline; Surveys and Questionnaires; Treatment Outcome; Walking | 2012 |
8 other study(ies) available for sertraline and Heart Failure
| Article | Year |
|---|---|
Effect of depression and sertraline treatment on cardiac function in female nonhuman primates.
Topics: Analysis of Variance; Animals; Atherosclerosis; Body Weights and Measures; Comorbidity; Depression; Diet; Disease Models, Animal; Echocardiography; Female; Heart; Heart Failure; Heart Rate; Humans; Hydroxyindoleacetic Acid; Macaca fascicularis; Male; Myocardium; Placebos; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride | 2014 |
Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.
Topics: Aged; Biomarkers; Chronic Disease; Comorbidity; Depressive Disorder, Major; Female; Heart Failure; Humans; Inflammation; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2015 |
The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.
Topics: Aged; Antidepressive Agents; Chronic Disease; Defibrillators, Implantable; Depression; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Quality of Life; Refractory Period, Electrophysiological; Selective Serotonin Reuptake Inhibitors; Sertraline; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
Sadness in heart failure: what is a clinician to do?
Topics: Antidepressive Agents; Depression; Heart Failure; Humans; Sertraline | 2010 |
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
Topics: Aged; Antidepressive Agents; Chronic Disease; Controlled Clinical Trials as Topic; Depression; Female; Heart Failure; Humans; Inpatients; Male; Middle Aged; Personality Inventory; Prevalence; Psychiatric Status Rating Scales; Remission Induction; Research Design; Sertraline; Severity of Illness Index; Treatment Outcome | 2011 |
Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.
Topics: Aged; Biomarkers; Cohort Studies; Depression; Female; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |